September 10, 2015 AMRA, BerGenBio and Nexstim receive Nordic Stars 2015 Awards at NLSDays in Stockholm
September 08, 2015 First patients enter phase II CARAT trial to assess reduction in atherosclerotic plaque using CER-001 in post Acute Coronary Syndrome (ACS) patients
September 04, 2015 Cerenis Therapeutics announces the publication of positive preclinical data in the world-renowned scientific journal PLOS ONE
September 04, 2015 Strongbridge Biopharma plc Announces Appointment of Matthew Pauls to its Board of Directors
August 31, 2015 Cortendo Announces Filing of Registration Statement for Proposed Initial Public Offering